tokens: Forty - three ovarian cancer patients were available for analysis following six cycles of the same PAC - containing regimen : 23 had been supplemented by glutamate all along the treatment period , at a daily dose of three times 500 mg ( group G ), and 20 had received a placebo ( group P ). Patients were evaluated by neurological examinations , questionnaires and sensory - motor nerve conduction studies .